JP2008543902A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543902A5
JP2008543902A5 JP2008517423A JP2008517423A JP2008543902A5 JP 2008543902 A5 JP2008543902 A5 JP 2008543902A5 JP 2008517423 A JP2008517423 A JP 2008517423A JP 2008517423 A JP2008517423 A JP 2008517423A JP 2008543902 A5 JP2008543902 A5 JP 2008543902A5
Authority
JP
Japan
Prior art keywords
combination
proanthocyanidins
days
composition
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008517423A
Other languages
English (en)
Other versions
JP2008543902A (ja
Filing date
Publication date
Priority claimed from US11/166,510 external-priority patent/US20060293258A1/en
Application filed filed Critical
Publication of JP2008543902A publication Critical patent/JP2008543902A/ja
Publication of JP2008543902A5 publication Critical patent/JP2008543902A5/ja
Pending legal-status Critical Current

Links

Claims (12)

  1. 患者における下肢の潰瘍を予防または処置するための組み合わせであって
    局所投与のためのプロアントシアニジンを含む第1の組成物の有効量;および
    経口投与のためのプロアントシアニジンを含む第2の組成物の有効量を含み、ここで、該組み合わせは該患者に投与され、それにより該下肢の潰瘍が予防または処置される、組み合わせ
  2. 前記第1の組成物が、粉末、ゲル、クリーム、ローション、水性アルコール溶液、懸濁物、または半固体からなる群から選択される局所形態である、請求項1に記載の組み合わせ
  3. 前記第2の組成物が、丸剤、ドリンク、粉末、食品添加物、粉末、カプセル、時間放出カプセルからなる群から選択される経口形態である、請求項1に記載の組み合わせ
  4. 前記プロアントシアニジンが、10%〜100%のプロアントシアニジンを含むプロアントシアニジン豊富植物抽出物である、請求項1に記載の組み合わせ
  5. 前記局所的組成物が、防腐剤、抗炎症剤、鎮痛剤、創傷治療剤またはそれらの組み合わせをさらに含む、請求項1に記載の組み合わせ
  6. 約20mg〜約10mg/患者/日のプロアントシアニジンが局所的に投与される、請求項1に記載の組み合わせ
  7. 約20mg〜約10mg/患者/日のプロアントシアニジンが経口的に投与される、請求項1に記載の組み合わせ
  8. 前記投与が、処置期間の経過に亘って各日に周期的な基盤で付与される、請求項1に記載の組み合わせ
  9. 前記投与する工程が、少なくとも30日、少なくとも42日、少なくとも60日、少なくとも90日または少なくとも120日の期間の間、毎日、前記プロアントシアニジンを投与することを含む、請求項1に記載の組み合わせ
  10. 前記プロアントシアニジンが、植物材料からの抽出物として提供される、請求項1に記載の組み合わせ
  11. 前記プロアントシアニジンが、マツ樹皮から抽出される、請求項10に記載の組み合わせ
  12. 前記マツ樹皮が、Pinus pinaster(海岸松)からである、請求項11に記載の組み合わせ
JP2008517423A 2005-06-23 2006-06-23 皮膚潰瘍を処置するための方法および組成物 Pending JP2008543902A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/166,510 US20060293258A1 (en) 2005-06-23 2005-06-23 Method and composition to treat skin ulcers
PCT/EP2006/006048 WO2006136428A2 (en) 2005-06-23 2006-06-23 Method and composition to treat skin ulcers

Publications (2)

Publication Number Publication Date
JP2008543902A JP2008543902A (ja) 2008-12-04
JP2008543902A5 true JP2008543902A5 (ja) 2009-08-06

Family

ID=37568333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008517423A Pending JP2008543902A (ja) 2005-06-23 2006-06-23 皮膚潰瘍を処置するための方法および組成物

Country Status (6)

Country Link
US (1) US20060293258A1 (ja)
EP (1) EP1896010A2 (ja)
JP (1) JP2008543902A (ja)
AU (1) AU2006261108A1 (ja)
CA (1) CA2612750A1 (ja)
WO (1) WO2006136428A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2469742C2 (ru) * 2006-07-21 2012-12-20 Марс, Инкорпорейтед Снижение уровней/активности аргиназы
US20120308525A1 (en) * 2009-11-25 2012-12-06 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
BR112015002030B8 (pt) * 2012-08-07 2022-11-29 Indus Biotech Private Ltd Uso de uma composição que compreende procianidina do tipo a pentamérica, procianidina trimérica e procianidina tetramérica, opcionalmente, juntamente com excipiente farmaceuticamente aceitável
JPWO2014104064A1 (ja) * 2012-12-26 2017-01-12 株式会社エーゼット 創傷治癒促進剤
US10398664B2 (en) 2013-05-01 2019-09-03 Lanny Leo Johnson Methods of diagnosing and treating infected implants
US10016380B2 (en) 2013-05-01 2018-07-10 Lanny Leo Johnson Antimicrobials and methods of use thereof
US9498413B2 (en) 2013-05-01 2016-11-22 Lanny Leo Johnson Antimicrobials and methods of use thereof for wound healing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
JPS6377390A (ja) * 1986-09-20 1988-04-07 Sanyo Electric Co Ltd キヤプスタンモ−タサ−ボ回路
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
US5470874A (en) * 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
BR9902972B1 (pt) * 1999-07-16 2012-02-22 composição bifásica de uso cosmético ou farmacêutico.
KR100509119B1 (ko) * 1999-07-16 2005-08-18 주식회사 엘지생활건강 프로시아니딘 올리고머를 유효성분으로 하는 약제
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
JP2005047818A (ja) * 2002-07-29 2005-02-24 Toyo Shinyaku:Kk 健康食品および健康飲料
JP2005047839A (ja) * 2003-07-31 2005-02-24 Toyo Shinyaku:Kk プロアントシアニジン含有組成物

Similar Documents

Publication Publication Date Title
AlAttas et al. Nigella sativa and its active constituent thymoquinone in oral health
Kumar et al. Emerging trends of herbal care in dentistry
JP2008543902A5 (ja)
JP5199674B2 (ja) サンギナリア属またはタケニグサ属の抽出物を含む組成物
US20110091572A1 (en) Acne treatment compositions comprising nanosilver and uses
JP2005508936A5 (ja)
WO2001001932A3 (en) Oligosaccharide aldonic acids and their topical use
CA2647356A1 (en) Compositions for hair loss disorders comprising extracts from the plant vernonia sp.
Thangavelu et al. Ancient seed for modern cure–pomegranate review of therapeutic applications in periodontics
KR101861347B1 (ko) 여러 기원의 말초 궤양 치료를 위한 조성물
CN1927160A (zh) 漱口液及制备方法
JP2002526407A5 (ja)
CN109276475A (zh) 一种含白及多糖中药牙膏及其制备方法
WO1997035599A1 (en) Composition for prevention and treatment of periodontal diseases
NZ547396A (en) Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
Subbiah et al. Herbals and green synthesized nanoparticles in dentistry
WO2000062751A3 (en) Oral care compositions containing boswellia extracts
Rashmi et al. Pharmacotherapeutic properties of ginger and its use in diseases of the oral cavity: A narrative review
WO2006022762B1 (en) Compositions and methods for the management of hyperproliferative dermatological conditions
Forouzanfar et al. The effect of green tea mouthwash (Camellia sinensis) on wound healing following periodontal crown lengthening surgery; a double blind randomized controlled trial
US11318093B2 (en) Dental topical anesthetic gel
CA2848570C (en) Compositions for the treatment of peripheral ulcers of various origins
Akbar et al. Quercus infectoria G. Olivier (Fagaceae) (Syns.: Q. boissieri Reut.; Q. carpinea Kotschy ex A. DC; Q. grosseserrata Kotschy ex Wenz.; Q. puberula O. Schwarz; Q. thirkeana K. Koch)
Boyapati et al. Herbal treatments used as an alternative in the treatment of Periodontal Diseases
Gupta et al. Nutraceuticals in Periodontal Health and Diseases in Dogs and Cats